OCULID
Oculid offers advanced eye tracking technology for smartphones. We provide an easy and remote testing solution for market and UX research teams to measure visual attention and engagement. Our platform allows you to test digital products, ad campaigns and packaging on mobile phones using the selfie camera. Our data analysis shows how a design performs and which design elements can be optimized. Oculid’s testing platform is easy to use, remote and reliable. It allows research teams to conduct studies anywhere in the world, directly on participants' mobile devices at the comfort of their home, and get in-lab quality insights at a fraction of the cost.
OCULID
Industry:
Consumer Research Human Computer Interaction Market Research Software UX Design
Founded:
2018-04-10
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.oculid.com
Total Employee:
11+
Status:
Active
Contact:
+49 30 28619787
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Euro JsDelivr Cloudflare JS CDN JS AJAX Libraries API
Similar Organizations
Twentify
Twentify is a consumer research platform that allows companies to conduct market research quickly and directly with target consumer base.
Current Employees Featured
Stefan Ruff Co-Founder @ Oculid
Co-Founder
Klaas Filler Co-Founder @ Oculid
Co-Founder
Mariana Macedo Marques Marketing Manager @ Oculid
Marketing Manager
2021-04-01
Antje Venjakob Co-Founder @ Oculid
Co-Founder
Founder
Investors List
IBB Ventures
IBB Ventures investment in Seed Round - Oculid
Newest Events participated
Official Site Inspections
http://www.oculid.com Semrush global rank: 5.75 M Semrush visits lastest month: 1.45 K
- Host name: w8f.rzone.de
- IP address: 81.169.145.95
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "Oculid"
Create an organization and manage users
An organization represents the company or individual associated with an app, and the organization’s name is shown with the app in the Meta Horizon Store. You can use the …See details»
Oculis
Experience the Future of Eye Care: Oculis, a Clinical Biopharmaceutical Innovator, Pioneering Breakthrough Treatments for Ophthalmic Diseases & Transforming Lives Globally.See details»
Meet Our Team - Oculis
Led by an experienced management team and supported by leading investors and expert board members, as well as global thought leaders in ophthalmology.See details»
About Us - Ophthalmology Companies - Oculis
Oculis is a global biopharmaceutical company purposefully driven to save sight and improve eye care.See details»
Oculid - Crunchbase Company Profile & Funding
Oculid offers a smartphone eye tracking solution that allows companies to gain insights into people's attention, opinion and behavior.See details»
Oculis - Crunchbase Company Profile & Funding
Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.See details»
Oculid Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Oculid. Use the PitchBook Platform to explore the full profile.See details»
Oculis | Investors and Media
The Investor Relations website contains information about Oculis's business for stockholders, potential investors, and financial analysts.See details»
Oculid - Products, Competitors, Financials, Employees, …
About Oculid Oculid specializes in advanced eye tracking technology for smartphones within the user experience testing domain. The company provides a platform for remote user experience …See details»
oculid (oculid GmbH) - Startbase
Remote usability testing of mobile applications is of increasing importance. However, tools that are currently on the market do not allow for deep insights into users‘ cognitive processes as they focus on superficial methods that do not …See details»
Oculis | Oculis Announces Pricing of $100 Million Oversubscribed ...
ZUG, Switzerland, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on …See details»
Oculis Labs - Crunchbase Company Profile & Funding
Oculis Labs is a security company providing computer-related services to protect computer screens from over-the-shoulder peepers.See details»
Oculis - LinkedIn
Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple …See details»
Oculis | Oculis Hosts R&D Event Today to Showcase Progress on …
5 days ago The event will provide an update on Oculis’ portfolio of three innovative late-stage clinical candidates, offer further details on the recently disclosed ACUITY clinical results and …See details»
Oculid Company Profile - Office Locations, Competitors, Revenue …
Oculid has 5 employees at their 1 location. See insights on Oculid including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Oculis Opens New Offices in the US and Expands its US Team
Apr 26, 2023 Oculis’s finance and development team strengthened by US-based hires, including Dr. Fang Li as Senior Vice President, Regulatory Affairs, who successfully led important FDA …See details»
Oculis Operations Sàrl – Swiss Biotech
Oculis is a biopharmaceutical company purposefully driven to save sight & improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in …See details»
Oculis | Oculis Reports Q4 and Full Year 2024 Financial Results and ...
Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro …See details»
Oculis Company Profile - Office Locations, Competitors, Revenue …
Oculis has 5 employees across 4 locations. See insights on Oculis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Oculis to Host In-Person and Virtual R&D Day on Key Business
Apr 1, 2025 Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and BeyondSee details»